AAVantgarde Bio
PrivateLast Round
Series B
Nov 3, 2025
Total Funding Raised
$206.3M
Company Overview
AAVantgarde Bio is a biotechnology company specializing in gene therapy for inherited retinal disorders, utilizing proprietary Adeno-Associated Viral (AAV) vector platforms to overcome cargo capacity limitations and effectively deliver large genes to ocular and non-ocular tissues.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AAVantgarde Bio Comps
Public and private peers based on sector, stage, and business model.
AAVantgarde Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 3, 2025 | ||||
| Series A | Jun 6, 2023 | ||||
| Seed | Jun 1, 2021 |
Key People
Founding team and executive leadership
AAVantgarde Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series A |
| Sixty Degree Capital | Series B |
| XGEN Venture | Series B |
| Forbion | Series B |
| Neva SGR | Series B |
| Athos KG | Series B |
| Accomplice | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
- Nov 3, 2025
$141M round completed.
AAVantgarde Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AAVantgarde Bio's valuation, stock price, and market status.
